Search results
AbbVie's Arthritis Drug Humira Retains Market Dominance...Competition, Challenges Biosimilar ...
Benzinga· 6 hours agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year ...
2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
Zacks via Yahoo Finance· 2 days agoZacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 11 hours agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew...
After A 40% Fall Is Walgreens Stock A Better Pick Over CVS Health?
Forbes· 2 days agoGiven its better valuation, we believe Walgreens stock (NYSE: WBA) is a better pick than its peer ...
NJ health care, pharmaceutical companies cutting jobs as tech disrupts industry
The Bergen Record via Yahoo News· 12 hours ago“This shift is also due to changes in research and development, drug failures, the end of...
From an Era of Well-washing to Championing the 50-plus Consumer, 9 Takeaways From WSL Strategic...
WWD via Yahoo News· 23 hours ago“The population is aging, and as they’re aging they’re saying, ‘I don’t just want to be here and...
As pharmacies shutter, Black and Latino communities are left behind
WFXT via Yahoo News· 4 days agoOpening stores used to mean everything to pharmacy chains. CVS Health once boasted of opening or...
A crisis is hitting your local drugstore. Why the slow demise of a 130-year-old family-owned...
Fortune via Yahoo Finance· 4 days agoSeattle's beloved Bartell’s, now owned by debt-laden Rite Aid, is closing many of its locations....
Prescription for trouble: Pennsylvania pharmacists say PBMs are driving pharmacy closures
Pennsylvania Capital-Star via Yahoo News· 5 days agoFor years, pharmacists have been warning that this trend could drive community pharmacies out of...
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 4 days agoWalgreens has signed a deal with Boehringer Ingelheim to use its community pharmacies as clinical...